ENTA FY3Q18 results—royalty revenue=$57.3M (+30% QoQ); GAAP EPS=$0.97: https://www.enanta.com/investors/news-releases/press-release/2018/Enanta-Pharmaceuticals-Reports-Financial-Results-for-its-Fiscal-Third-Quarter-Ended-June-30-2018/default.aspx